BITALSHIN

This brand name is authorized in Nigeria.

Active ingredients

The drug BITALSHIN contains one active pharmaceutical ingredient (API):

1
UNII SW9M9BB5K3 - PHENOBARBITAL SODIUM
 

Phenobarbital has sedative effects and has some protective action against all varieties of human partial and generalised epilepsy, with the exception of absence seizures. Phenobarbital is also effective in preventing seizures in the corresponding experimental animal models of epilepsy.

 
Read more about Phenobarbital

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-101140 Solution for injection Bitalshin 100 mg/mL Injection INJ_SOL 100 mg/mL 1 mL x 100's (in amber glass ampoules) Sterile solution for injection in 1-mL amber glass ampoule. A clear, colorless liquid 18/12/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N03AA02 Phenobarbital N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives
Discover more medicines within N03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-101140

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.